Products Used in Early Phase IND Studies

  • Free
  • Published date: November 27, 2017
    • Fremont, California, United States

Overview:
How it may be integrated with the recommendations of the guidance documents on CMC requirements.

Areas Covered in the Session:
Discussion of the elements found in the guidance document for Phase 1 material
What to do at really early stages
What about special IND studies?
What about preclinical studies?

Who Will Benefit:
Regulatory Affairs personnel who coordinate activities for the CMC sections of submissions
QA/QC personnel who need to plan work on early stage material
R & D personnel who will contribute data to CMC sections
Project managers for product development studies
Quality systems auditors
Consultants

Speaker Profile:
Steven S. Kuwahara , Ph.D. is the founder and Principal of GXP BioTechnology LLC, a consulting firm that works in the areas covered by the GLP and GMP of drugs, biologics, and nutraceuticals. Steve has over 30 years of experience in supervising quality control laboratories, including an animal testing facility, and in performing GLP and GMP audits of internal and external testing laboratories .

Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Full Details & Registration Link:
http://www.compliance4all.com/control/w_product/~product_id=501658LIVE?channel=marketplace_Jan_2018_SEO

Result 0 votes
Compliance4All
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Clinical Data Systems Regulated by FDA

    Clinical Data Systems Regulated by FDA

    Quality Control, Safety & Security Fremont (California) November 27, 2017 Free

    Overview: Companies engaged in the conduct of human clinical trials must adhere to specific government regulatory requirements.Certain documents, content and images related to a clinical trial must be stored and maintained, and depending on the regul...

  • NIST Cybersecurity Framework For Computer Systems Validation

    NIST Cybersecurity Framework For Computer Systems Validation

    Quality Control, Safety & Security Fremont (California) August 14, 2017 Free

    Overview: Computer systems used in highly regulated companies include sensitive and valuable information. Some of this information includes valuable electronic submissions, clinical information, medical device design control records, legal informatio...

  • FDA Inspection and Respond to 483 & How to Prepare them - 2017

    FDA Inspection and Respond to 483 & How to Prepare them - 2017

    Quality Control, Safety & Security Fremont (California) June 14, 2017 150.00 Dollar US$

    Overview: In this webinar you will learn about the types of FDA inspections, preparations such as assigning dedicated personnel to specific tasks for the inspection, facility requirements to support the inspection. Why should you Attend: FDA is requi...